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Summary We have studied the mitogenic, motogenic and morphogenic effects of hepatocyte growth factor (HGF), also known as scatter
factor (SF), on 15 non-small-cell lung carcinoma (NSCLC) cell lines that have had their ras genotype determined. HGF/SF stimulated
proliferation in only three cell lines and exerted no mitogenic activity on six lines. The growth of the remaining six lines was inhibited. The
mitogenic effects were not related to the ras genotype of these cell lines, but the inhibitory effect was more commonly observed in cell lines
with relatively high levels of Met/HGF receptor (HGFR) expression. HGF/SF induced or enhanced both scatter activity on monolayer culture
and single-cell invasion in collagen gels in approximately half of these cell lines. Although the ras genotype of tumour cells did not influence
the HGF/SF-induced motogenic activity, cell lines with the mutant ras genotype more commonly demonstrated a spontaneous motogenic
activity than those with the wild-type ras genotype. When tumour cells were grown in collagen gels, HGF/SF induced irregular branching
extensions of cell aggregates formed by five out of eight adenocarcinoma cell lines, but significant lumen morphogenesis was distinctly
absent. The presence of autocrine HGF/SF loop in these tumour cell lines did not influence their spontaneous or HGF/SF-induced mitogenic,
motogenic or morphogenic activities. Overall, our data suggest that stimulation of cell motility, rather than proliferation or differentiation, is the
predominant paracrine effect of HGF/SF on NSCLC cells in vitro.
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Hepatocyte growth factor (HGF), also known as scatter factor
(SF), was originally and independently isolated as a hepatic regen-
eration factor (Nakamura et al, 1987) and as a fibroblast-derived
motogen (Stoker et al, 1987; Weidner et al, 1991). The mature
form of HGF/SF is a heterodimer of a 69-kDa cx-chain and a 34-
kDa [-chain. These are processed by proteolytic cleavage from a
single-chain precursor propeptide of 90 kDa. This cleavage is
mediated by a serine protease HGF activator and urokinase-type
plasminogen activator (Naldini et al, 1992; Miyazawa et al, 1993).
Although HGF/SF is primarily elaborated by mesenchymal cells,
its primary effects are on epithelial cells, with activities on cellular
proliferation and movement, and on tissue morphogenesis
(Weidner et al, 1990; Montesano et al, 1991; Rosen et al, 1994;
Matsumoto and Nakamura, 1996). HGF/SF is also a potent angio-
genic factor (Bussolino et al, 1992; Grant et al, 1993). Its receptor
(HGFR) is the protein product of the c-met proto-oncogene (Met)
that encodes a receptor tyrosine kinase (Park et al, 1986; Bottaro et
al, 1991). The heterodimeric Met/HGFR consists of an extra-
cellular oc-chain and a transmembrane [-chain linked by disulphide
bonds. Ligand-receptor interaction results in autophosphorylation
of tyrosine (Tyr)-1234 and Tyr-1235 residues of the [-chain of
Met/HGFR, and an activation of its intrinsic tyrosine kinase
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activity (Longati et al, 1994; Zhu et al, 1994a). This leads to the
autophosphorylation ofTyr-1349 and Tyr-1356 residues, which are
essential for the signal transduction of its pleiotrophic effects
(Ponzetto et al, 1994; Zhu et al, 1994b). These tyrosine residues are
essential binding sites for the SH2 domains of p85 regulatory
subunit of phosphatidylinositol 3-kinase (PI3-kinase), phospho-
lipase C-y (PLC-y), pp6sr,, Shc and Grb2 (Graziani et al, 1991;
Okano et al, 1993; Ponzetto et al, 1994; Pelicci et al, 1995).
Met/HGFR activation also stimulates mitogen-activated protein
kinase (MAP kinase)/ERK (Halaban et al, 1992), Ras (Graziani
et al, 1993), and p125 focal adhesion kinase (FAK) (Matsumoto
et al, 1994). Recent data indicate that binding of the activated
Met/HGFR to Grb2 is necessary for the branching tubulogenic
effect of HGF/SF on Madin-Darby canine kidney (MDCK) cells
(Fournier et al, 1996; Ponzetto et al, 1996), whereas its association
with P13-kinase mediates the scattering effect of HGF/SF (Royal
and Park, 1995; Ponzetto et al, 1996). In contrast, the mitogenic
effect of HGF/SF appears to involve primarily MAP kinase activa-
tion and c-fos induction (Nagamine et al, 1996).
Most lung cancer cells express Met/HGFR (Di Renzo et al,
1991; Rygaard et al, 1993), and it is overexpressed in approxi-
mately 40% ofprimary lung adenocarcinoma tissue (Liu and Tsao,
1993a). The expression of HGF/SF by lung cancer cells in vitro
and in vivo has also been reported (Yoshinaga et al, 1992; Tsao et
al, 1993; Harvey et al, 1996; Olivero et al, 1996). A recent publi-
cation also indicated that high levels ofHGF/SF protein content in
primary non-small-cell lung carcinoma (NSCLC) was correlated
with poor prognosis, suggesting that paracrine and/or autocrine
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Table 1 The phenotypic and genotypic properties of 15 non-small-cell lung carcinoma cell lines and the mitogenic effect of HGF/SF on them
Met/HGFR HGF mRNA Ras genotype HGF effect on
Histotype Cell line proteina expressionb (WT/GGT)c proliferation
ADC MGH-8 ..- Kl2 (GAT) No effect
MGH-13 ++ - WT Stimulation
MGH-24 ... + WT Inhibition
A549 ++ ++ K12 (AGT) Inhibition
RVH-6849 .. - WT Inhibition
NCI-H358 ..- K12 (TGT) No effect
ADSQC MGH-30 ... + K12 (TGT) Inhibition
NCI-H125 +++- WT Inhibition
SQCC MGH-7 ++ ++ WT Inhibition
NCI-H157 + - K12 (CGT) No effect
NCI-H226 ++ ++ WT Stimulation
NCI-H520 0 - WT No effect
NCI-H1264 + ++ K12 (CGT) No effect
LCUC MGH-4 + + WT Stimulation
NCI-661 0 + WT No effect
ADC, adenocarcinoma; ADSQC, adenosquamous cell carcinoma; SQCC, squamous cell carcinoma; LCUC, large cell undifferentiated carcinoma. aRelative
expression levels of Met/HGFR were scored based on the result presented in Figure 1: 0, not detectable; +, low; ++, moderate; +++, high. bCell lines with wild-
type ras gene were designated as WT; cell lines with oncogenic ras genotype were designated by their mutated ras gene: Kl2, codon 12 of Ki-ras gene; the
parenthesis indicates the sequence of the mutant codon. cRelative levels of HGF/SF mRNA expression is based on the RPA results presented in Figure 2: 0,
not detected; +, low; ++, moderate. None of these cell lines express HGF/SF at levels that are similar to the high levels expressed by fibroblast cell lines.
functions of HGF/SF may play important roles in the biology of
lung cancer cells (Siegfried et al, 1997). We report here the results
of our studies on the mitogenic, motogenic and morphogenic
activities of recombinant HGF/SF in 15 NSCLC cell lines that
have had their ras genotype determined.
MATERIALS AND METHODS
Recombinant human HGF/SF was purified from the conditioned
media ofmammalian cell lines transfected by an expression vector
containing full-length cDNA ofhuman HGF/SF (Montesano et al,
1991; Zioncheck et al, 1995). The stock solutions were stored
in aliquots at -70°C The specific activities of different lots of
HGF/SF preparations were checked using scatter assay on MDCK
(Madin-Darby Canine Kidney) cells and were found to be similar.
Cell lines and cell culture
The NSCLC cell lines included those previously established in our
laboratory (Liu and Tsao, 1993b) and at the NCI-Navy, Bethesda,
MD, USA (Phelps et al, 1996). A549 and MDCK cell lines were
purchased from the American Type Culture Collection (Rockville,
MD, USA). Cell lines were cultured in either RPMI-1640 medium
plus 10% fetal bovine serum or ACL-4 medium. RPMI-1640
medium and fetal bovine serum were purchased from Gibco BRL
(Grand Island, NY, USA). ACL-4 serum-free medium was
prepared as previously reported (Gazdar and Oie, 1986), but
without supplementation with epidermal growth factor (EGF).
HGFR/Met protein
The HGFR/Met protein levels ofthe cell lines were determined in
cultures that had become confluent. Total cellular proteins were
extracted in an aqueous buffer containing 50 mmol 1-' Hepes
(pH 8.0), 1% Triton X-100, 10% glycerol, 150 mmol 1-', I0 mmol 1-'
EDTA, 100mmol 1-' sodium fluoride, 10mm sodium pyrophos-
phate, 1 gg ml' leupeptin, 1 ,ug ml-' aprotinin. After centrifugation
at 13 000g for 10 min, the supernatant was collected. Fifty-micro-
gram protein extracts were electrophoretically separated in an 8%
sodium dodecyl sulphate (SDS)-polyacrylamide gel, and transfered
on to nitrocellulose membrane. After blocking with 5% milk in
TBST buffercontaining 10 mmol 1-' Tris-HCI (pH 7.0), 0.1% Tween
20, 2.5 mmol 1-' EDTA and 50 mmol 1- sodium chloride, the
membrane was incubated with a polyclonal rabbit antibody against
h-Met (catalogue no. SC-161, Santa Cruz Biotech, Santa Cruz, CA,
USA), and subsequently revealed using the BM Chemiluminescence
Western Blotting Kit (Boehringer Mannheim Canada, Dorval,
Quebec, Canada).
HGF mRNA expression
Significant levels of HGF mRNA expression were determined
using the RNAase protection assay (RPA). An HGF/NK2 cDNA
was cloned using the reverse transcriptase polymerase chain
reaction (RT-PCR) technique and subcloned into the pGEM-4Z
plasmid (Promega, Madison, WN, USA). This cDNA of 446-bp
encodes the nucleotides 645-1071 of the alternatively spliced
human HGF-NK2 variant mRNA (Miyazawa et al, 1993). The
authenticity of this cDNA was confirmed by sequencing, and its
orientation established by hybridization to Northern blots of RNA
from MRC-5 and human lung fibroblast cell lines (unpublished
data). 32P-labelled antisense HGF cRNA was synthesized from
HindIII linearized plasmid using the SP6 RNA polymerase. Total
cellular RNA was extracted from cultured tumour cells that have
grown to confluence, and 50 ,ug of RNA was used in each RPA
analysis, using the RPAII ribonuclease protection assay kit
purchased from Ambion (Austin, TX, USA).
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ras genotype
The genotypes ofthese cell lines forHa-ras, Ki-ras and N-ras were
identified using polymerase chain reaction (PCR) followed by
hybridization with allele (mutant)-specific oligonucleotide probes
(PCR-ASOH method), as described previously (Tsao et al, 1997).
Cell proliferation
The mitogenic effect ofHGF/SF was assayed by the incorporation
of [3H]methyl-thymidine (Tdr) into the cellular DNA, as previ-
ously reported (Tsao et al, 1993). Briefly, 3000-4000 cells were
plated into each well of replicate Falcon's 12-well tissue culture
plates (Becton Dickinson, Bedford, MA, USA). The cells were
allowed to enter exponential growth phase 2-4 days after plating,
the medium was then replaced with either fresh serum-containing
medium (control) or the same medium containing 0.5-10 ng ml-'
of HGF/SF. Three to 4 days later, 1 gCi of [3H]Tdr (67 Ci mole-',
ICN Canada, St Laurent, Quebec, Canada) was added into each
well, and cells were further incubated for 20-24 h. They were then
thoroughly washed in succession with cold phosphate-buffered
saline (PBS), 5% trichloroacetic acid (TCA), and 95% ethanol
solution. The plates were then air dried. The DNA was solubilized
by an overnight incubation in 0.3 N sodium hydroxide at 37°C, and
the radioactivity of incorporated [3H]Tdr was counted using a
Beckman LS6000 liquid scintillation counter. For each cell line,
the HGF/SF effect was assayed repeatedly for three to five times.
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Figure 1 Western blot analysis of Met/HGFR protein levels in NSCLC cell
lines. A 50-ig sample of total cellular protein extract from each cell line was
separated by 7.5% SDS-polyacrylamide gel electrophoresis (PAGE),
transferred onto nitrocellulose membranes, and immunoblotted with the
antibody to C-terminal peptide of human c-met. The 170-kD precursor (*) and
p145 3-chain of Met were detected using the enhanced chemiluminescence
reaction. To compare the protein levels of different cell lines, the MGH-8 cell
extract was included as a reference in each PAGE analysis. The comparative
levels of Met/HGFR protein expressed by these cell lines are summarized in
Table 1
Cell motility on a plastic surface
The scatter effect ofHGF/SF on each cell line was recorded during
the performance of the mitogenic assay using an inverted phase-
contrast microscope (see above). With some lines, cells cultured
on 35-mm Falcon tissue culture plates were induced to scatter by
HGF/SF, then fixed in a solution containing methanol-acetic
acid-dH2O (20:5:75) for 10 min. Afterrinsing with distilled water,
cells were stained with PBS containing 4% Giemsa, then air dried.
Microphotographs were taken using an inverted microscope.
Three-dimensional collagen gel culture
Collagen gels were prepared using rat tail type 1 collagen (Becton
Dickinson, Bedford, MA, USA). The collagen culture medium was
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prepared by mixing 10 x RPMI-1640 medium containing the
appropriate amount of sodium bicarbonate, fetal bovine serum,
5 mg ml-' stock solution of type I collagen, and 0.125 N sodium
hydroxide in 1:1:4:4 volume proportions. The collagen medium was
aliquoted into 12-well culture plates to form a 1-mm-thick basal
layer. Afterincubation at 37°C for20 minto harden the gel, the same
aliquot ofcollagen medium containing 1-2.5 x 104cells was overlaid
onto the basal layer. Afterthe gels had solidified, liquid medium was
added, and the plates were returned to the incubator. After 5-7 days'
culture allowing the suspended cells to form small cysts the medium
was replaced by fresh medium with or without 10ng ml-' of
HGF/SF Morphological changes were observed and photographed
directly using an inverted phase-contrast microscope. After4 days of
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Figure 2 The ribonuclease protection assay (RPA) for HGF/SF mRNA expression in NSCLC cell lines. For each RPA reaction, 50 9g of total cellular RNA was
used. Using the NK2 cRNA probe (see Materials and methods), the full-length HGF mRNA transcript (HGF-FL) is expected to yield a 301-bp protected
fragment, whereas mRNA transcript of the NK2 variant of HGF mRNA is expected to yield a 462-bp protected fragment. The nature of other minor bands is
unknown and may represent uncharacterized alternatively spliced HGF/SF mRNA transcripts. The comparative levels of the 301 bp HGF-FL protected fragment
are summarized in Table 1
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incubation, the gels were harvested and fixed in 10% buffered
formalin and embedded in paraffin. Sections were prepared, stained
routinely with haematoxylin and eosin and evaluated using light
microscopy.
RESULTS
Genotypic and phenotypic characteristics of the
NSCLC cell lines
Table I summarizes the histological classification of all 15
NSCLC cell lines studied, their ras genotypes and their relative
levels of HGFR/Met protein and HGF/SF mRNA expression. Six
cell lines had oncogenic activation of their Ki-ras gene. All cell
lines except two (NCI-H520 and -H661) expressed variable
Met/HGFR protein (Figure 1). The lines that did not show
detectable HGFR protein also lacked Met mRNA expression by
Northern blot analyses (data not shown). RPA detected HGF/SF
mRNA expression in 8 of 15 (53%) cell lines (Figure 2); seven
of these also co-expressed HGFR/Met mRNA and protein. The
concentrated conditioned media of these HGF/SF-expressing cell
lines also induced the scattering of MDCK cells, suggesting the
secretion of HGF/SF protein and autocrine loop formation in these
cells (Tsao et al, 1993).
Effect of HGF/SF on cell proliferation
Among the fifteen NSCLC cell lines, HGF/SF stimulated the
monolayer proliferation ofonly three lines, MGH-4, -13 and NCI-
H226 (Figure 3). The stimulation was concentration dependent,
with the maximum effect reached at 2-5 ng 1-'. HGF/SF did not
significantly affect the proliferation of six cell lines, but it inhib-
ited the growth ofthe remaining six lines (MGH-7, -24, -30, A549,
RVH6849 and NCI-H125). This inhibition was also concentration
dependent. In a majority ofcell lines affected, the maximum effect
was observed at 5-10 ng 1- HGF/SF.
The mitogenic effect of HGF/SF was not correlated with the
histological type oftumour cells (Table 1). Among six adenocarci-
noma (ADC) cell lines, HGF/SF stimulated the proliferation of
one line (MGH-13), showed no effect in two lines (MGH-8 and
NCI-H358) and was inhibitory in three other lines (MGH-24,
A549 and RVH-6849). Among five squamous cell carcinoma
(SQCC) cell lines, one was stimulated (NCI-H226), one was
slightly inhibited (MGH-7) and three were not affected (NCI-
H157, -H520 and -H1264). Both adenosquamous carcinoma
(ADSQC) cell lines (MGH-30 and NCI-H125) were inhibited, but
the effect on the two large-cell undifferentiated carcinoma
(LCUC) cell lines (MGH-4, NCI-H66) was heterogeneous. As
expected, the two cell lines that did not express HGFR/Met
expression (NCI-H520 and -H661) also were not responsive to the
mitogenic effect of HGF. The cell lines that were growth stimu-
lated (MHG-13 and -4, NCI-H226) showed either low or inter-
mediate Met/HGFR levels. In contrast, the majority of cell lines
that were inhibited by HGF/SF showed high levels ofMetIHGFR
expression. Neither the ras genotype nor the presence ofa putative
HGF/SF autocrine loop appeared to influence the mitogenic
responses of these cells to exogenous HGF/SF.
Motogenic and invasion effect of HGF/SF
Cells were assessed for scatter activity in low-density cultures,
both spontaneously in routine medium and after treatment with
_ MGH-13(ADC)
c NCH-H226(SQCC)
MGH-4(LCUC)
240
--220
r- 200-
0
*~10 -6 180
0-- 140
0.
2120-
j' 100
V 80r a l T
0.50 1.00 2.00 5.00 10.00
NCI-H358(ADC)
NCI-H157(SOCC)
NCI-H661(LCUC)
MGH-8(ADC)
NCI-H1264(SQCC)
NCI-H520(SOCC)
r--
120 -
C
0 o 100
*6
.be 80
-a 0.
60-
0.50
120
el
c 100
C)
06
e 80
-
a 60
0.
i. 40
20
fl
2.00 5.00 10.00
A549(ADC)
RVH6849(ADC)
MGH-7(SQCC)
MGH-30(ADSO)
NCI-H125(ADSQ)
MGH-24(ADC)
0.50 1.00 2.00 5.00 10.00
HGF (ng ml-')
Figure 3 The mitogenic effect of HGF/SF on 15 NSCLC cell lines. The
effect on proliferation is measured by the incorporation of [3H]thymidine into
the acid insoluble fraction of the cellular DNA after incubation in medium
containing various concentrations of HGF/SF. The results are presented as
the per cent incorporation compared with control untreated cells, the values
being the means with standard error of means of three to six separate
assays. Dashed lines indicate the 100% incorporation level of the control
cells
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Figure 4 A representative microphotographs demonstrating the spontaneous and HGF/SF induced scatter activities in NSCLC cell lines. The NCI-Hi25 cells
(A) normally demonstrated insignificant spontaneous scatter activity, whereas the A549 cells (B) showed a slight degree of spontaneous scatter activity. The
treatment with 10 ng ml-' HGF/SF resulted in marked scatter activities in both cell lines (C H125; D A549). The microphotographs were taken on Giemsa-
stained fixed cells, with the bar representing approximately 100,m
Table 2 The spontaneous and HGF/SF induced motogenic activity of NSCLC cell lines on a plastic surface and in collagen gels
Cell motility phenotypesa
Scattering (plastic surface) Invasion (collagen gel)
Ras
genotype Histotype Cell line Control HGF/SF Control HGF/SF
Mutant ADC MGH-8 + T + T
A549 + T + T
NCI-H358 0 + + T
ADSQC MGH-30 0 NC 0 NC
SQCC NCI-H157 + NC + NC
NCI-H1264 + NC + NC
Wild type ADC MGH-13 0 NC 0 +
MGH-24 0 NC 0 NC
RVH-6849 + 1 0 +
ADSQC NCI-H125 0 + 0 +
SQCC MGH-7 0 NC 0 NC
NCI-H226 0 + + T
NCI-H520 0 NC + NC
LCUC MGH-4b 0 NC NA NT
NCI-H661 0 NC 0 NC
aWhen tumour cell lines cultured at colony-forming densities or in collagen gels demonstrated individual cell dispersion, they were scored to show scattering or
invasion phenotypes. When these phenomena were noted in the absence of HGF/SF, they were designated as spontaneous activity (+) under the control
columns. After treatment with HGF/SF, these activities were either induced (+) or enhanced (1). If the activities were similar before and after HGF/SF treatment,
they were designated as NC (no change). bMGH-4 cell line did not form colonies in collagen gel, hence was not evaluated for its invasive property in collagen
gel. NA, not assessed. The cell lines were segregated according to their ras genotypes and histogenesis. SQOCC, squamous cell carcinoma; ADSQC,
adenosquamous carcinoma; ADC, adenocarcinoma; LCUC, large cell undifferentiated carcinoma.
10 ng ml' HGF/SF. Scatter activity was considered absent when
tumour cells grew only as tight colonies (Figure 4A), but was
considered present when some cells dispersed individually
between colonies (Figure 4B-D). When compared with the
untreated cells, the HGF/SF-induced scatter activity was scored as
either induced, enhanced or unchanged (Table 2). Five cell lines
showed varying degrees of spontaneous motility, and it was partic-
ularly marked in NCI-H157 and NCI-H1264. Four cell lines with
spontaneous scatter activity had a mutation in their Ki-ras gene
(Table 2). Only one of the nine cell lines with wild-type ras
genes showed spontaneous scatter activity. The difference was
statistically significant (Table 3), indicating a correlation between
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Table 3 The influence of ras genotype and autocrine HGF/SF loop in
NSCLC cell lines on their spontaneous or HGF/SF induced/enhanced cell
motility on a plastic surface
Spontaneous motility
Absent Present P-value
Ras genotype
Wild type 8 1
0.011
Mutant 2 4
HGF/SF autocrine loop
Absent 4 3
0.608
Present 6 2
HGF/SF induced/enhanced motility
Absent Present P-value
Ras genotype
Wild type 6 3
0.622
Mutant 3 3
P-values were evaluated using Fisher's exact test, two-tailed.
oncogenic ras activation and spontaneous motogenic activity in
NSCLC cells. In contrast, there was a lack of correlation between
the occurrence ofspontaneous cellular motility and the presence of
a putative HGF/SF autocrine loop (Table 3).
Treatment with 2 ng ml-' or higher concentrations of HGF/SF
induced or enhanced cell scattering in six NSCLC cell lines
A
(MGH-8, A549, RVH-6849, NCI-H125, -H226 and -H358). In
two other lines (NCI-H157 and NCI-H1264) that demonstrated
the greatest spontaneous motility, further stimulation of scatter
activity by HGF/SF could not be evaluated. Both lines with no
detectable HGFR/Met levels (NCI-H520 and -H661) also did not
show HGF/SF-induced scattering. The ability of HGF/SF to
induce or enhance cell motility in these NSCLC cells and the
degree of such effects was not influenced by the ras genotype or
the levels ofMet/HGFR on the cells (Table 3).
The ability ofthese tumour cells to invade and migrate as single
cells inside collagen gels was also evaluated (Figure 5 and Table 2).
Four cell lines that demonstrated varying degrees of spontaneous
scatter activity (MGH-8, A-549, NCI-H157 and -H1264) in mono-
layer culture, also showed varying degrees of spontaneous single
cell invasion activity in collagen gels. Three other cell lines (NCI-
H358, -H226 and -H520) additionally demonstrated a slight degree
of such activity. HGF/SF induced or enhanced the collagen gel
invasion activity in seven cell lines (MGH-8, A549, NCI-H358,
MGH-13, NCI -H125, NCI-H226 and RVH-6849). There was an
excellent correlation between the ability ofHGF/SF to induce these
cells to scatter on a plastic surface and in collagen gels.
Morphogenic effect of HGF/SF
In collagen gels, all SQCC cell lines form irregular cell clusters,
whereas most ofADC cell lines formed either round or rod-shaped
cell aggregates (Figure 6A), which were composed of solid cords
of cells without lumens formation (Figure 5A and C). After the
addition of HGF/SF, none of the SQCC cell lines demonstrates
morphogenic activity, whereas the cell aggregates of five ADC
cell lines (A549, NCI-H358, MGH-30, MGH-13 and RVH-6849)
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Figure 5 The ability of NSCLC cells to demonstrate single-cell invasion or locomotion in collagen gels. Cells were seeded in 2.0 mg 1-' collagen type gels and
allowed to form colonies spontaneously (A and C). After colonies have formed, duplicate wells were treated with 10 ng 1-' HGF/SF (B and D). After a further 3-4
days' incubation, the gels were removed from the plates and fixed in 10% buffered formalin solution, embedded in paraffin, and sections were prepared and
stained with haematoxylin and eosin. RVH-6849 cells formed tight colonies in control untreated gels (A) but demonstrated single-cell scattering and invasion
after treatment with HGF/SF (B). In contrast, NCI-H358 cells demonstrated a slight degree of spontaneous single cells invasion (C), but this activity was
markedly enhanced after treatment with HGF/SF (D). The bar lengths represent approximately 50 ,um
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Figure 6 The 'morphogenic activity' of NSCLC cells in collagen gels. MGH-30 cells formed round colonies (A) when grown in collagen gels but demonstrated
irregular branchings of these cell aggregates after treatment with HGF/SF (B). The bar lengths represent approximately 50 gm
showed varying degrees of and irregular branching extensions
(Figure 6B). Histological sections, however, failed to show signif-
icant lumen formations in these branching cell cords. The ability to
show 'branching extensions' was not influenced by the ras geno-
type of these cell lines.
DISCUSSION
We have investigated the mitogenic, motogenic and morphogenic
properties of fifteen NSCLC cell lines with known ras genotype
and their responses to exogenous treatment with recombinant
human HGF/SF. The results indicated that HGF/SF may have
significant motogenic and morphogenic effects on these lung
cancer cells, but a growth stimulatory effect occurred in only a
minority of these cell lines.
Recombinant human HGF/SF exerted heterogeneous mitogenic
effects on these cell lines, with six (40%) lines showing no response,
and six others (40%) showing an inhibitory effect. Only three cell
lines (20%) demonstrated significant growth stimulatory effect.
Interestingly, the effect of HGF/SF on the proliferation of lung
cancer cell lines has not been extensively reported, and ours repre-
sents the most comprehensive study on this subject. Among the four
NSCLC cell lines that were studied and reported previously (Tajima
et al, 1992; Yoshinaga et al, 1992; Singh-Kaw et al, 1995), HGF/SF
stimulated growth in two lines (SQCC and LCUC respectively), and
was ineffective in two others. None of these lines was derived from
ADC. It is possible that the paucity of reports on the growth stimula-
tory effect of HGF/SF on lung cancer cells may actually reflect the
infrequence of such findings, and this would be consistent with our
results. The mitogenic effect ofHGF/SF on other human tumour cell
lines are very heterogeneous. HGF/SF inhibits the proliferation of
all seven human hepatocellular carcinoma cell lines studied (Shiota
et al, 1992), demonstrates no significant mitogenic effect on four out
offive gastric carcinoma cell lines (Tanafel et al, 1994; Nagamine et
al, 1996), and stimulates the growth of three of five malignant
melanoma cell lines (Kan et al, 1991; Halaban et al, 1992). In
contrast, HGF/SF consistently stimulates the proliferation ofnormal
human epithelial cells in cultures. These include primary cultures of
hepatocytes (Nakamura et al, 1987), mammary (Niranjan et al,
1995), biliary (Strain et al, 1995) and bronchial (Tsao et al, 1993)
epithelia, keratinocytes (Matsumoto et al, 1991) and melanocytes
(Halaban et al, 1992). It is worth noting that the activation of over-
expressed tyrosine kinase receptors often leads to a suppression of
cell proliferation, independent of the activation of the p21"-'s and
MAP kinase (Osterop et al, 1994). This may explain the inability of
constitutive ras activation to block the HGF/SF induced inhibition
ofproliferation in some of these NSCLC cell lines.
Our results have largely confirmed the prominent motogenic
effect of HGF/SF on epithelial cells cultured on plastic surface
and in collagen gels, including neoplastic cells. Among thirteen
Met/HGFR expressing NSCLC cell lines that we studied, HGF/SF
induced or enhanced scattering in six lines. Two other lines already
demonstrated high levels of spontaneous cellular motility that
precluded the evaluation of further enhancement. There is a very
good correlation between the ability of these tumour cells to move
on a plastic surface and in collagen gels, suggesting that the
primary effect of HGF/SF is on cell movement, regardless of the
environment of these cells. Recent reports suggested that the
binding and activation of P13-kinase, but not Grb-2/Sos-Ras path-
ways is important in HGF/SF-induced cell motility in MDCK cells
(Fournier et al, 1996; Ponzetto et al, 1996). This would be consis-
tent with our findings that the ability of HGF/SF to induce moto-
genic activity is not affected by the constitutive activation of the
ras signal transduction pathway. Despite an absence of correlation
between the presence of HGF/SF autocrine loop and spontaneous
scatter activity, an autocrine motility function of HGF/SF in some
of these NSCLC cells cannot be completely excluded. This
requires further studies that use techniques to silence the HGF/SF
expression and/or function. Recent reports indicated that a signifi-
cant proportion of primary NSCLC overexpress HGF/SF and
Met/HGFR (Harvey et al, 1996; Olivero et al, 1996; Takanami et
al, 1996), and high levels ofHGF/SF in these tissues may be corre-
lated with a poor overall survival rate (Siegfried et al, 1997). The
most important biological process that affects the survival or prog-
nosis of lung cancer patients is metastasis, and cellular motility is
one of the critical cellular functions during metastasis.
The observation that oncogenic ras activation is correlated with
the spontaneous motogenic activity supports a hypothesis that the
ras oncogene may promote early metastasis in NSCLC. Several
studies have demonstrated that ras mutations in ADC is a poor
prognostic factor, especially for early-stage disease (Rodenhuis
and Slebos, 1992; Sugio et al, 1992). These patients usually die of
distant metastatic recurrences.
Another important function of HGF/SF-Met/HGFR interaction is
in morphogenesis, especially in the formation of three-dimensional
tubular/glandular structures (Montesano et al, 1991). This effect has
been demonstrated in vitro in normal epithelial cells, including
human and mouse mammary epithelial cells (Niranjan et al, 1995),
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epithelial cell lines derived from normal human prostate (Brinkmann
et al, 1995) and mouse bile ductular and pancreatic epithelial cells
(Johnson et al, 1993; Jeffers et al, 1996). In these normal cells, these
branching cords ofcells demonstrate lumen formations, thus consis-
tent with glandular differentiation. We have also observed HGF/SF
induced 'branching extensions' when lung ADC cell lines were
cultured in collagen gels, but these structures fail to show gland
lumen morphogenesis. In contrast, thesebranching cell cords showed
irregular extensions that are more consistent with promotion of cell
movement or dispersion. There is actually very scant published
evidence to indicate that the glandular morphogenic activity of
HGF/SF is functionally and commonly maintained in neoplastic
cells. Brinkmann et al (1995) studied the morphogenic activity of
HGF/SF in 64 human carcinoma cell lines of various organs and
reported significant morphogenic activities in only three of these
lines. Among the six lung carcinoma cell lines they studied, HGF/SF
demonstrated induction of morphogenic activity in two lines, but
only one (LX-1) line showed significant 'alveolar'-like lumen forma-
tion. In fact, only the LX-1 cell line that has been transfected by and
is autocrinely expressing HGF/SF showed this effect, which is lost
when a neutralizing antibody to HGF/SF was added. This indicates
that the parent LX-I cells do not spontaneously form alveolar struc-
tures. The discrepancy between normal and cancer cells in their
morphogenic responses to HGF/SF may be caused by post-receptor
modification of the MetlHGFR signal transduction pathways, or by
alteration in the cytoskeletal filament organization in neoplastic cells.
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